Workflow
Lier Chemical (002258)
icon
Search documents
利尔化学(002258) - 2020 Q3 - 季度财报
2020-10-23 16:00
Financial Performance - Operating revenue for the period was ¥1,011,023,668.35, representing a year-on-year growth of 4.04%[10] - Net profit attributable to shareholders was ¥161,329,562.95, a significant increase of 115.49% year-on-year[10] - The basic earnings per share for the period was ¥0.3077, up 115.48% compared to the same period last year[10] - Operating profit for the period was ¥199,697,962.77, up from ¥93,047,642.62, reflecting a significant improvement in operational efficiency[76] - Net profit attributable to the parent company was ¥161,329,562.95, compared to ¥74,865,639.19 in the same period last year, representing a growth of 115.5%[80] - Total comprehensive income for the current period was ¥450,875,901.92, compared to ¥277,339,373.97 in the previous period, marking a significant increase[93] Assets and Liabilities - Total assets at the end of the reporting period reached ¥7,797,721,295.27, an increase of 2.78% compared to the end of the previous year[10] - The company's current assets totaled CNY 2,884,564,122.09, slightly down from CNY 2,886,530,650.50 at the end of 2019[55] - Total liabilities decreased to CNY 3,309,543,810.34 from CNY 3,552,507,019.07, a reduction of approximately 6.9%[61] - Total assets amounted to ¥5,748,685,310.06, up from ¥5,441,474,520.99, showing a growth of 5.6%[71] - Total liabilities increased slightly to ¥2,413,974,768.16 from ¥2,408,791,949.33, indicating stable financial leverage[71] Cash Flow - The net cash flow from operating activities was ¥107,288,917.34, a decrease of 41.37% year-on-year[10] - Cash flow from operating activities was CNY 408,353,749.52, compared to CNY 398,716,641.35 in the previous period, reflecting a slight increase[101] - Cash inflow from financing activities was CNY 359,630,495.21, down 42.7% from CNY 626,822,446.51 in the previous period[108] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 21,722[15] - The largest shareholder, Sichuan Jiuyuan Investment Holding Group Co., Ltd., held 27.36% of the shares[15] - The company did not engage in any repurchase transactions among the top 10 shareholders during the reporting period[22] Investments and Development - The company indicated plans for market expansion and new product development in the upcoming quarters[39] - The company is focusing on enhancing its research and development capabilities to drive innovation in its product offerings[39] - Research and development expenses were ¥52,052,478.58, an increase from ¥44,903,687.99, highlighting the company's commitment to innovation[76] Government Support and Subsidies - The company received government subsidies amounting to ¥21,325,005.54 during the reporting period[10] - Other income rose by 42.17% to 2,085.78 million, primarily due to an increase in government subsidies related to income[26] Financial Management and Controls - The company has implemented internal control measures for foreign exchange trading to mitigate risks associated with derivative investments[43] - There were no violations regarding external guarantees during the reporting period[48] - There were no non-operating fund occupations by controlling shareholders or related parties during the reporting period[49] Future Guidance - The company provided guidance for future revenue growth, projecting an increase of approximately 10% year-over-year for the next quarter[39]
利尔化学(002258) - 2020 Q2 - 季度财报
2020-08-05 16:00
Financial Performance - The company's operating revenue for the first half of 2020 was CNY 2,348,895,340.91, representing a 14.44% increase compared to CNY 2,052,519,274.34 in the same period last year[22]. - The net profit attributable to shareholders was CNY 255,408,964.36, a significant increase of 60.11% from CNY 159,520,425.13 in the previous year[22]. - The net profit after deducting non-recurring gains and losses was CNY 240,884,166.31, up 49.84% from CNY 160,757,222.81 year-on-year[22]. - The net cash flow from operating activities reached CNY 301,064,832.18, an increase of 39.57% compared to CNY 215,712,921.78 in the same period last year[22]. - Basic earnings per share rose to CNY 0.4871, reflecting a 60.12% increase from CNY 0.3042 in the previous year[22]. - The diluted earnings per share was CNY 0.4752, up 56.21% from CNY 0.3042 year-on-year[22]. - The weighted average return on equity increased to 7.33%, compared to 4.99% in the same period last year, marking a 2.34% rise[22]. - Total assets at the end of the reporting period were CNY 7,609,447,231.25, a slight increase of 0.30% from CNY 7,586,558,498.59 at the end of the previous year[22]. - The net assets attributable to shareholders increased by 7.64% to CNY 3,614,770,025.74 from CNY 3,358,104,181.16 at the end of the previous year[22]. Revenue Breakdown - In the first half of 2020, the company achieved a consolidated revenue of 2.349 billion yuan, representing a year-on-year growth of 14.44%[42]. - The net profit attributable to the parent company was 255 million yuan, an increase of 60.11% compared to the previous year[42]. - International sales accounted for 39.87% of total revenue, increasing by 29.02% to ¥936,529,706.38 from ¥725,870,735.24[48]. - Domestic sales increased by 7.47% to ¥1,408,193,417.16 from ¥1,310,277,642.41, representing 59.95% of total revenue[48]. Investment and Assets - Fixed assets increased by 17.71% compared to the beginning of the year, mainly due to the completion of construction projects[33]. - The company invested CNY 269,060,425.62 in the Guang'an base construction project, with a cumulative actual investment of CNY 1,928,651,390.34 by the end of the reporting period[59]. - The expected cumulative actual benefits from the Guang'an project are CNY 387,000,000.00, with a progress completion rate of 53.41%[59]. - The total investment during the reporting period was ¥388,601,339.82, a decrease of 12.00% from ¥441,602,766.07 in the same period last year[57]. Environmental Management - The company has implemented a comprehensive environmental management system, achieving ISO14001 certification[38]. - The company has invested over 700 million CNY in environmental protection measures in recent years, ensuring compliance with national standards for waste emissions[95]. - The company has upgraded and enhanced its environmental protection facilities, ensuring stable operation and effective treatment of wastewater, waste gas, and solid waste[150]. - The company has constructed a 10,000 Nm³/h VOCs low-concentration waste gas incineration furnace and a 30,000 m³/h activated carbon adsorption treatment system[154]. - The company has implemented a leak detection and repair program, completing four inspections with a 100% repair rate for identified leaks[153]. Corporate Social Responsibility - The company has committed to participating in national poverty alleviation initiatives as part of its corporate social responsibility efforts[161]. - The company invested a total of 216,200 CNY in poverty alleviation efforts during the first half of 2020[164]. - The investment in agricultural and forestry industry poverty alleviation projects amounted to 133,400 CNY[164]. - The company provided financial assistance of 2,000 CNY to one impoverished student as part of its education poverty alleviation initiative[167]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period is 24,913, with a significant shareholder, Sichuan Jiuyuan Investment Holding Group Co., Ltd., holding 27.36% (143,484,136 shares) of the total[183]. - The company’s total shares increased to 524,378,017 after the conversion of convertible bonds and other adjustments[176]. - The largest shareholder, Sichuan Jiuyuan Investment Holding Group Co., Ltd., has 7,501,272 shares frozen[183]. - The company has not experienced any changes in its controlling shareholder or actual controller during the reporting period[189]. Risk Management - The company has implemented measures to mitigate risks associated with foreign exchange fluctuations and customer payment delays[71]. - The company emphasized the importance of actively managing accounts receivable to ensure timely payments from clients[71]. - The company has faced risks related to market competition, raw material supply and price fluctuations, environmental regulations, safety production, and large-scale construction investments[95].
利尔化学(002258) - 2020 Q1 - 季度财报
2020-04-21 16:00
Financial Performance - The company's operating revenue for Q1 2020 was ¥980,776,297.84, a decrease of 3.64% compared to ¥1,017,783,095.28 in the same period last year[10] - Net profit attributable to shareholders was ¥83,380,824.15, an increase of 15.41% from ¥72,245,409.40 year-on-year[10] - Basic earnings per share increased to ¥0.1590, reflecting a growth of 15.38% compared to ¥0.1378 in the same period last year[10] - The company reported a total revenue of 2,834.0 million for the period ending March 13, 2020, with a growth rate of 0.00%[36] - Total operating revenue for the current period was approximately CNY 619.50 million, a slight increase from CNY 617.79 million in the previous period, representing a growth of 0.11%[79] - Operating profit for the current period was CNY 82.89 million, compared to CNY 73.22 million in the previous period, indicating an increase of 13.67%[79] - Net profit for the current period was CNY 71.49 million, up from CNY 65.02 million in the previous period, reflecting a growth of 9.66%[79] - The net profit attributable to the parent company's shareholders was CNY 83.38 million, compared to CNY 72.25 million in the previous period, showing an increase of 15.00%[75] Cash Flow and Liquidity - The net cash flow from operating activities was ¥26,643,401.43, down 83.62% from ¥162,662,002.48 in the previous year[10] - Cash received from sales of goods and services decreased by 30.21% to 71,893.91 million yuan due to a decline in sales revenue[23] - Operating cash inflow for the current period was CNY 771,247,457.79, a decrease of 30% from CNY 1,101,404,838.35 in the previous period[83] - The ending balance of cash and cash equivalents was CNY 713,989,317.86, down from CNY 812,396,362.88 in the previous period[89] - The net increase in cash and cash equivalents for the current period was CNY 53,725,556.31, compared to CNY 236,751,877.00 in the previous period, reflecting a decrease of 77%[89] Assets and Liabilities - Total assets at the end of the reporting period were ¥7,717,093,219.80, up 1.72% from ¥7,586,558,498.59 at the end of the previous year[10] - The total liabilities increased to CNY 2,882,000,000.00, reflecting a rise in short-term borrowings to CNY 576,827,539.68 from CNY 445,821,080.64[54] - The total liabilities amounted to ¥3,593,066,754.10, an increase from ¥3,552,507,019.07 in the previous period[60] - The total equity attributable to shareholders reached ¥3,441,887,806.27, up from ¥3,358,104,181.16 in the previous period[60] - The total current assets were CNY 2,886,530,650.50, with cash and cash equivalents at CNY 739,070,107.17[95] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 32,025[15] - The largest shareholder, Sichuan Jiuyuan Investment Holding Group Co., Ltd., held 27.36% of the shares[15] - The company did not engage in any repurchase transactions among the top 10 shareholders during the reporting period[19] Operational Insights - The company experienced an indirect economic loss of approximately 1 million yuan due to a material incident at the Mianyang base[26] - The company plans to enhance safety management and employee training following the incident[26] - User data indicates a consistent trend with no significant changes in user engagement metrics during the reporting period[36] - New product development initiatives are underway, although specific details on new products were not disclosed in the call[36] - The company is considering market expansion strategies to enhance its presence in key regions, although no specific regions were mentioned[36] - There are no current plans for mergers or acquisitions as part of the company's growth strategy[36] Research and Development - Research and development efforts are ongoing, with a focus on improving existing product lines[36] - Research and development expenses for the current period were CNY 57.70 million, down from CNY 72.63 million in the previous period, a decrease of 20.54%[74] Financial Management - The company reported non-operating income of ¥5,622,702.36 for the period, after accounting for tax and minority interests[10] - Financial expenses decreased by 61.82% to 1,463.46 million yuan mainly due to increased foreign exchange gains[23] - The company has implemented risk control measures for derivative investments, including internal control management systems[50] - There were no violations regarding external guarantees or non-operating fund occupation by controlling shareholders during the reporting period[44]
利尔化学(002258) - 2019 Q4 - 年度财报
2020-03-11 16:00
Financial Performance - The company reported a total revenue of 1.2 billion RMB for the year 2019, representing a year-on-year growth of 15%[19] - The net profit attributable to shareholders was 150 million RMB, an increase of 20% compared to the previous year[19] - The company's operating revenue for 2019 was ¥4,163,842,124.04, representing a 3.40% increase compared to the previous year[26] - The net profit attributable to shareholders decreased by 46.15% to ¥311,142,625.53 from ¥577,810,917.87 in 2018[26] - The net profit attributable to shareholders after deducting non-recurring gains and losses fell by 49.58% to ¥301,030,394.95[26] - The basic earnings per share decreased by 46.15% to ¥0.5934[26] - The diluted earnings per share also decreased by 44.67% to ¥0.5934[26] - The total assets at the end of 2019 were ¥7,586,558,498.59, a 15.42% increase from the previous year[29] - The net assets attributable to shareholders increased by 6.36% to ¥3,358,104,181.16[29] - The company reported a weighted average return on equity of 9.64%, down from 21.38% in 2018, a decrease of 11.74%[29] - The company achieved total revenue of 4.164 billion yuan, an increase of 3.4% compared to the same period last year[53] - The net profit attributable to shareholders was 311 million yuan, a decrease of 46.14% year-on-year[53] Research and Development - The company plans to invest 200 million RMB in R&D for new product development in the upcoming year[19] - Research and development expenses rose by 33.70% to ¥221,222,478.79, reflecting the company's commitment to technological innovation[70] - R&D investment increased by 33.70% from 165,465,384.71 CNY in 2018 to 221,222,478.79 CNY in 2019, representing 5.31% of operating revenue[73] - The number of R&D personnel rose to 411, a 0.74% increase from 408 in 2018, while the proportion of R&D personnel to total employees decreased by 0.93%[73] - The company has ongoing projects for new product development, including L-草铵膦 and other series, to secure future growth[72] Market Expansion and Strategy - The company has outlined a future outlook with a revenue growth target of 10-15% for 2020[19] - Market expansion efforts include entering two new international markets, aiming for a 5% market share in each by 2021[19] - A strategic acquisition of a smaller competitor is under consideration to enhance market position[19] - The company aims to strengthen cooperation with international clients and focus on new product development and market collaboration[106] - The company is exploring potential mergers and acquisitions to strengthen its market position and expand its product offerings[190] Operational Efficiency - The company has implemented new technologies in production, leading to a 12% reduction in operational costs[19] - The company has established a financial shared service center, procurement center, and human resources center to optimize management systems[54] - The company has not experienced any major safety or environmental quality incidents during the reporting period, reflecting its commitment to safety and environmental management[54] - The company has implemented strict monitoring mechanisms for safety and environmental management, ensuring compliance with relevant laws and regulations[175] Environmental Responsibility - The company has invested over ¥700 million in environmental protection measures in recent years, ensuring compliance with national standards[110] - The company adheres to environmental protection standards, with wastewater discharge meeting the comprehensive discharge standards, including 41.41 tons per annum of COD and 2.57 tons per annum of ammonia nitrogen[182] - The company has implemented new strategies for market expansion and product development, focusing on sustainable practices and compliance with environmental regulations[190] - The company has invested in environmental protection, upgrading waste treatment facilities and optimizing production processes to reduce emissions[195] - The company completed environmental protection self-inspection for multiple projects in March 2019, including a production line for 2500 tons of chloraminopyridine acid raw materials[198] Financial Management and Profit Distribution - The company has no plans to distribute cash dividends or issue bonus shares for the year[7] - The company plans not to distribute cash dividends for the year 2019, nor to issue bonus shares or convert capital reserves into share capital[122] - The company's profit distribution policy emphasizes reasonable returns to investors while ensuring sustainable development[118] - The company can adopt cash, stock, or a combination of both for profit distribution, prioritizing cash dividends[118] - The company must have positive distributable profits and sufficient cash flow to implement cash dividends[118] - The company has a structured decision-making process for profit distribution, involving independent directors and shareholder feedback[121] - The company has not proposed a cash dividend distribution plan despite having positive profits available for distribution[125] - The company’s cash dividend policy is compliant with its articles of association and shareholder resolutions[122] - The company did not distribute cash dividends in 2019, with a net profit of CNY 311.14 million, resulting in a cash dividend payout ratio of 0.00%[126] Social Responsibility - The company actively engages in social responsibility, focusing on economic, social, and environmental benefits, while ensuring compliance with safety and environmental regulations[175] - In 2019, the company provided assistance to 5 employees in extreme difficulty through its charity fund, totaling approximately CNY 39,000, and helped 43 employees through the labor union, amounting to nearly CNY 56,000[175] - The company organized over 150 employees for voluntary blood donation, contributing a total of 42,000 milliliters in 2019[175] - The company has established 13 employee interest groups with over 700 participants, enhancing corporate culture and employee engagement[175] - The company plans to increase its efforts in targeted poverty alleviation in 2020, continuing its support for local agricultural development[181]
利尔化学(002258) - 2019 Q3 - 季度财报
2019-10-25 16:00
Financial Performance - Operating revenue for the period was CNY 971,747,720.57, representing a 2.10% increase year-on-year[10] - Net profit attributable to shareholders decreased by 52.63% to CNY 74,865,639.19 compared to the same period last year[10] - The net profit after deducting non-recurring gains and losses fell by 53.98% to CNY 77,789,657.97 year-on-year[10] - Basic earnings per share decreased by 52.62% to CNY 0.1428[10] - The weighted average return on net assets was 2.31%, down by 3.50% from the previous year[10] - Net profit for the current period was ¥81,974,943.13, down from ¥170,665,098.01 in the previous period, reflecting a decrease of approximately 52.0%[68] - Basic earnings per share decreased to ¥0.1428 from ¥0.3014, a decline of about 52.7%[71] - Net profit for the current period was ¥277,339,373.97, down 39.6% from ¥460,124,435.01 in the previous period[78] - The company reported a total comprehensive income of ¥277,339,373.97 for the current period, down from ¥460,124,435.01 in the previous period[81] - Net profit for the period was ¥158,833,915.01, down from ¥384,984,181.06, indicating a decrease of about 58.7% compared to the previous year[87] Assets and Liabilities - Total assets increased by 11.88% to CNY 7,353,687,469.27 compared to the end of the previous year[10] - The total number of shareholders at the end of the reporting period was 26,489[15] - Total liabilities increased to CNY 3,481,621,616.60, up from CNY 2,887,076,145.34, representing a growth of approximately 20.5% year-over-year[52] - Current liabilities totaled CNY 2,214,557,732.57, compared to CNY 1,748,426,981.92, reflecting an increase of about 26.7%[52] - Non-current liabilities rose to CNY 1,267,063,884.03 from CNY 1,138,649,163.42, marking an increase of approximately 11.3%[52] - The company’s total liabilities increased significantly, with accounts payable rising by 127.95% to 71,735.54 million RMB due to increased supplier bank acceptance bills[27] - Total current assets amounted to ¥2,999,082,430.62, an increase from ¥2,605,616,174.25 in the previous year[46] - Total assets amounted to CNY 4,697,633,690.96 as of January 1, 2019[114] - Total liabilities reached CNY 1,764,764,165.00 as of January 1, 2019[115] Cash Flow - Cash flow from operating activities increased by 61.30% to CNY 183,003,719.57 compared to the same period last year[10] - Net cash flow from operating activities improved by 38.84% to 39,871.66 million RMB, driven by cash received from sales of goods and services[30] - The company’s cash and cash equivalents net increase was down by 57.32% to 3,359.71 million RMB, mainly due to reduced financing net amounts[30] - Cash and cash equivalents decreased to ¥529,184,846.12 from ¥650,839,399.14 year-on-year[46] - Cash inflow from financing activities was ¥626,822,446.51, up from ¥497,038,902.40 in the previous period[98] - Net cash flow from financing activities decreased to ¥145,771,380.15 from ¥295,095,790.82 in the previous period[98] Research and Development - Research and development expenses increased by 53.67% to 17,320.99 million RMB, reflecting a continued commitment to R&D investment[27] - Research and development expenses were ¥44,903,687.99, slightly down from ¥45,265,505.89, a decrease of about 0.8%[65] - Research and development expenses rose to ¥173,209,921.41, a significant increase of 53.7% compared to ¥112,715,597.54 in the previous period[78] - Research and development expenses increased significantly to ¥118,885,160.11 from ¥70,788,961.08, reflecting a rise of approximately 67.9% year-over-year[84] Shareholder Information - The largest shareholder, Sichuan Jiuyuan Investment Holding Group Co., Ltd., holds 27.36% of the shares[19] - The company reported no non-operating fund occupation by controlling shareholders or related parties during the reporting period[37] - There were no violations regarding external guarantees during the reporting period[36] - The company did not engage in entrusted financial management during the reporting period[38] Legal and Compliance - The company has been actively involved in litigation regarding employee compensation disputes, with ongoing legal proceedings since 2014[31] Market Outlook - The company aims to enhance market expansion and product development strategies in the upcoming quarters[80]
利尔化学(002258) - 2019 Q2 - 季度财报
2019-08-16 16:00
Financial Performance - The company's operating revenue for the first half of 2019 was CNY 2,052,519,274.34, representing a year-on-year increase of 12.68%[34]. - The net profit attributable to shareholders of the listed company was CNY 159,520,425.13, a decrease of 38.80% compared to the same period last year[34]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 160,757,222.81, down 39.28% year-on-year[34]. - Basic earnings per share were CNY 0.3042, down 38.81% from CNY 0.4971 in the same period last year[34]. - The company reported a net profit of -2,009,419.41 RMB due to losses from the disposal of machinery and equipment during the reporting period[42]. - The company achieved a consolidated revenue of RMB 2.05 billion in the first half of 2019, representing a year-on-year increase of 12.68%[58]. - The net profit attributable to the parent company was RMB 160 million, a decrease of 38.80% compared to the same period last year[57]. - The company expects a net profit for the period from January to September 2019 to be between CNY 16,748.30 million and CNY 29,309.53 million, representing a year-on-year decline of 30% to 60%[94]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 7,027,820,757.05, an increase of 6.92% from the end of the previous year[34]. - The net assets attributable to shareholders of the listed company were CNY 3,206,901,023.98, reflecting a 1.57% increase compared to the previous year[34]. - The company's cash and cash equivalents at the end of the reporting period were RMB 603.28 million, accounting for 8.58% of total assets, a decrease of 1.32% from the previous year[66]. - Accounts receivable stood at RMB 724.65 million, representing 10.31% of total assets, down by 1.76% year-on-year[66]. - The company has no significant changes in its financial assets and liabilities measured at fair value during the reporting period[69]. Investments and Capital Expenditure - The company invested approximately RMB 441.60 million during the reporting period, a decrease of 35.57% compared to RMB 685.36 million in the same period last year[71]. - The construction of the Guang'an base involved an investment of RMB 132.38 million during the reporting period, with a cumulative actual investment of RMB 1.41 billion[73]. - The total amount of raised funds was RMB 852 million, with RMB 1.91 million utilized during the reporting period, and a cumulative total of RMB 716.41 million invested[80]. - The company has invested CNY 1,906.37 million in committed investment projects during the reporting period, with the 1,000 tons of fluazinam production line project having a progress of 37.58%[81]. - The cumulative actual investment for the 15,000 tons of methyl dichlorophosphate project is CNY 1,212.15 million, with a project progress of only 1.21%[89]. Revenue Breakdown - The company's total revenue for the pesticide industry reached approximately RMB 1.95 billion, representing a year-on-year increase of 29.17%[65]. - Domestic sales accounted for RMB 1.31 billion, showing a significant growth of 34.47% compared to the previous year, while international sales increased by 19.90% to RMB 725.87 million[65]. - The revenue from pesticide raw materials was approximately RMB 1.35 billion, with a year-on-year growth of 30.68%, while pesticide formulations and others reached RMB 508.14 million, up by 30.09%[65]. Research and Development - The company increased its R&D investment to RMB 132.73 million, a significant rise of 107.66% year-on-year[61]. - The company has filed 22 invention patents in the first half of 2019, reflecting its commitment to innovation[57]. Environmental Compliance - The company is classified as a key pollutant discharge unit by environmental protection authorities[136]. - Total wastewater discharge amounted to 20.45 tons, with a permitted discharge limit of 205.2 tons per year[136]. - The concentration of COD in wastewater was reported at 18.56 mg/L, complying with the national discharge standards[136]. - The company has implemented continuous monitoring for various pollutants, ensuring compliance with environmental regulations[139]. - The company has invested in upgrading and enhancing its environmental protection facilities, ensuring stable operation and effective treatment of wastewater, waste gas, and solid waste[146]. Competition and Market Risks - The company faces risks including market competition, raw material price fluctuations, and environmental risks[7]. - The company faces significant competition pressure due to domestic competitors expanding production capacity, which may impact sales and profitability[95]. - Raw material costs constitute a large portion of operating costs, and price fluctuations could adversely affect gross margins and profitability[95]. Shareholder Information - The top shareholder, Sichuan Jiuyuan Investment Holding Group, holds 1,921,444 shares, representing 22.55% of the total[161]. - The largest shareholder, Sichuan Jiuyuan Investment Holding Group, holds 27.36% of the shares, totaling 143,484,136 shares[175]. - The total number of common shareholders at the end of the reporting period is 28,929[175]. - The total number of shares held by directors and senior management increased by 882,400 shares during the reporting period[192]. Corporate Governance - The company held its first extraordinary shareholders' meeting on July 9, 2019, to elect the fifth board of directors and supervisory board members[196]. - Yin Yingsui was elected as the chairman and appointed as the general manager of the company[196]. - The board of directors includes five non-independent directors elected during the meeting[196].
利尔化学(002258) - 2019 Q1 - 季度财报
2019-04-23 16:00
Financial Performance - The company's revenue for Q1 2019 was ¥1,017,783,095.28, representing a 12.48% increase compared to ¥904,849,549.85 in the same period last year[10] - Net profit attributable to shareholders decreased by 37.51% to ¥72,245,409.40 from ¥115,606,905.86 year-on-year[10] - The basic earnings per share fell by 37.51% to ¥0.1378 from ¥0.2205 in the same period last year[10] - Net profit attributable to shareholders decreased by 37.51% to 7,224.54 million, mainly due to a reduction in total profit[26] - The company expects net profit for the first half of 2019 to decline by 20% to 50% compared to the same period last year[29] - The net profit range for the first half of 2019 is estimated to be between 130,323.7 million and 208,517.9 million[31] - Net profit for the current period was ¥91,890,171.17, a decrease of 29.5% from ¥130,456,728.57 in the previous period[62] - Total comprehensive income attributable to the parent company was CNY 72,245,409.40, down from CNY 115,606,905.86 in the previous period, representing a decrease of approximately 37.5%[65] - Basic and diluted earnings per share decreased to CNY 0.1378 from CNY 0.2205, reflecting a decline of about 37.5%[65] - Operating profit decreased to CNY 73,222,647.84 from CNY 118,328,594.33, a decline of about 38.1%[66] - Net profit for the period was CNY 65,020,768.19, down from CNY 100,843,089.61, indicating a decrease of approximately 35.7%[66] Cash Flow - The net cash flow from operating activities surged by 655.96% to ¥162,662,002.48, compared to ¥21,517,270.63 in the previous year[10] - Cash inflow from operating activities totaled ¥651,993,744.97, up from ¥392,079,492.36 in the previous period, indicating a growth of approximately 66%[77] - Cash outflow from operating activities increased to ¥503,971,565.06 from ¥415,374,276.68, reflecting a rise of about 21%[77] - Cash flow from operating activities increased significantly to CNY 1,030,161,969.71 from CNY 723,891,106.18, representing a growth of approximately 42.4%[70] - Cash flow from investing activities showed a net outflow of CNY 197,216,549.32, improving from a net outflow of CNY 242,378,854.18 in the previous period[76] - Cash flow from financing activities generated a net inflow of CNY 273,140,355.18, down from CNY 527,202,881.43, a decrease of about 48.2%[76] - The ending cash and cash equivalents balance increased to CNY 812,396,362.88 from CNY 693,097,898.42, reflecting a growth of approximately 17.2%[76] - The net cash flow from operating activities was ¥148,022,179.91, a significant improvement compared to a net outflow of ¥-23,294,784.32 in the previous period, representing a turnaround of over 100%[77] Assets and Liabilities - Total assets increased by 7.72% to ¥7,080,156,390.88 from ¥6,572,840,788.84 at the end of the previous year[10] - Current assets increased to ¥3,004,104,858.87 as of March 31, 2019, up from ¥2,605,616,174.25 as of December 31, 2018, representing a growth of approximately 15.2%[40] - Total non-current assets reached ¥4,076,051,532.01, compared to ¥3,967,224,614.59, showing an increase of about 2.7%[43] - Total liabilities reached ¥3,423,392,170.62, compared to ¥2,887,076,145.34, indicating an increase of approximately 18.5%[46] - Current liabilities increased to ¥2,181,358,174.28 from ¥1,758,174,747.92, reflecting a rise of about 24.0%[46] - Total liabilities were reported at ¥2,887,076,145.34, indicating a stable financial position[88] - The total equity attributable to shareholders was ¥3,157,448,080.75, reflecting a solid equity base for the company[88] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 27,309[14] - The largest shareholder, Sichuan Jiuyuan Investment Holding Group Co., Ltd., held 27.36% of the shares, amounting to 143,484,136 shares[14] Research and Development - Research and development expenses surged by 128.81% to 7,263.14 million, reflecting increased investment in R&D[26] - Research and development expenses increased significantly to ¥72,631,361.03, compared to ¥31,743,328.57 in the previous period, reflecting a growth of 128.5%[59] - Research and development expenses surged to CNY 51,559,946.60 from CNY 17,624,928.95, an increase of about 192.5%[66] Other Financial Metrics - The company reported non-recurring gains and losses totaling ¥4,438,746.61 for the period[10] - Management expenses increased by 34.21% to 5,711.86 million due to the expansion of operational scale[26] - Other payables increased by 95.38% to 26,743.69 million, mainly due to undistributed dividends from 2018[26] - Tax expenses decreased by 35.97% to 1,553.72 million, primarily due to a reduction in total profit[26] - The company reported a significant increase in other income to ¥5,583,304.00 from ¥3,822,561.50, reflecting a growth of 46.1%[62] Audit and Reporting - The first quarter report was not audited[95]
利尔化学(002258) - 2018 Q4 - 年度财报
2019-02-22 16:00
Financial Performance - The company reported a total revenue of 1.2 billion yuan for the year 2018, representing a year-on-year increase of 15%[21]. - The net profit attributable to shareholders was 200 million yuan, an increase of 10% compared to the previous year[21]. - The company's operating revenue for 2018 was ¥4,027,069,339.69, representing a 30.60% increase from ¥3,083,547,891.99 in 2017[28]. - The net profit attributable to shareholders for 2018 was ¥577,810,917.87, a 43.75% increase compared to ¥401,967,199.04 in 2017[28]. - The net profit after deducting non-recurring gains and losses was ¥597,044,924.56, reflecting a 50.93% increase from ¥395,566,578.14 in 2017[28]. - The basic earnings per share for 2018 was ¥1.1019, up 43.74% from ¥0.7666 in 2017[28]. - The weighted average return on equity for 2018 was 21.38%, an increase of 3.27% from 18.11% in 2017[28]. - The company reported a net cash flow from operating activities of ¥348,038,821.24, a decrease of 4.12% from ¥362,985,438.38 in 2017[28]. - The company achieved a consolidated revenue of 4.03 billion yuan in 2018, representing a year-on-year growth of 30.60%[57]. - The net profit attributable to the parent company was 578 million yuan, an increase of 43.75% compared to the previous year[57]. Dividend Policy - The company plans to distribute a cash dividend of 2.00 yuan per 10 shares, amounting to a total payout of approximately 104.87 million yuan[8]. - The company proposed a cash dividend of 2 CNY per 10 shares for the fiscal year 2018, totaling 104,874,606 CNY, which represents 18.15% of the net profit attributable to shareholders[128]. - The net profit attributable to shareholders for 2018 was 577,810,917.87 CNY, with a cash dividend payout ratio of 100%[128]. - The company has maintained a consistent communication process with shareholders, especially minority shareholders, to gather their opinions on profit distribution[125]. - The company’s profit distribution policy is subject to adjustment based on significant changes in the external operating environment or its own operational status, ensuring shareholder rights are prioritized[125]. Market Expansion and Strategy - The company is focusing on expanding its market presence in Southeast Asia, targeting a 25% increase in market share by 2020[21]. - User data showed a growth in customer base by 20%, reaching 500,000 active users by the end of 2018[21]. - The company is exploring potential mergers and acquisitions to enhance its competitive position in the market[21]. - The company expanded its overseas market presence, achieving scale sales in Australia and the EU, and successfully registered products in Canada[57]. - The company aims to optimize its marketing structure and increase the proportion of formulation exports[111]. Research and Development - The company has invested 150 million yuan in research and development, aiming to enhance product quality and sustainability[21]. - Research and development expenses increased by 75.43% to CNY 165,465,384.71, driven by enhanced investment in technology innovation[76]. - The number of R&D personnel rose by 46.24% to 408, representing 9.76% of the total workforce[77]. - The company has established a strong R&D base in Mianyang, which is the largest production base for chlorinated pyridine herbicides in China[42]. - The company has established a strong technological advantage, being the second globally to master the integrated technology of pyridine compound catalytic chlorination[50]. Environmental and Safety Management - The company has invested approximately 500 million RMB in environmental protection facilities and management systems over recent years, ensuring compliance with national standards for waste emissions[3]. - The company has implemented an Environmental Health and Safety Department to strengthen safety management and reduce operational risks associated with hazardous materials[4]. - The company has conducted emergency drills for various hazardous material leaks, ensuring preparedness for environmental incidents[193]. - The company has established a comprehensive pollution prevention and control strategy, ensuring adherence to environmental standards[182]. - The company reported no exceedance of discharge limits for all monitored pollutants, demonstrating compliance with environmental regulations[179]. Financial Management and Investments - The company successfully issued convertible bonds, raising 852 million yuan for operational development[57]. - The company plans to raise up to RMB 852 million through the issuance of convertible bonds, which has been approved by the China Securities Regulatory Commission[197]. - The company plans to raise funds through bank loans and other channels to support its ongoing development[112]. - The total approved guarantee amount for subsidiaries during the reporting period was 85,500,000[167]. - The actual guarantee amount incurred during the reporting period was 52,091,030[167]. Operational Challenges and Risks - The management highlighted risks related to raw material price fluctuations and environmental regulations, which could impact future profitability[8]. - The fluctuation in raw material prices significantly impacts the company's operating costs and gross margin, with recent increases in commodity prices not fully offset by product price hikes, potentially reducing profitability[1]. - The company faces significant competition risks from domestic competitors expanding their production capacity[113]. - The company is undergoing large-scale capital expenditures for the Guang'an base project, which may lead to increased depreciation, interest costs, and operational expenses, affecting short-term performance[5]. Corporate Governance - The company has not engaged in any non-operating fund occupation by controlling shareholders or related parties during the reporting period[132]. - The company’s independent directors have fulfilled their responsibilities and contributed to the decision-making process regarding profit distribution[125]. - There were no significant litigation or arbitration matters during the reporting period[140]. - The company reported no penalties or rectification situations during the reporting period[141]. - The company has no bankruptcy reorganization matters during the reporting period[139].
利尔化学(002258) - 2018 Q3 - 季度财报
2018-10-25 16:00
利尔化学股份有限公司 2018 年第三季度报告正文 证券代码:002258 证券简称:利尔化学 公告编号:2018-066 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 实、准确、完整,不存在虚假记载、误导性陈述或者重大遗漏,并承担个别和 连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人尹英遂、主管会计工作负责人古美华及会计机构负责人(会计主 管人员)符眉冷声明:保证季度报告中财务报表的真实、准确、完整。 2 利尔化学股份有限公司 2018 年第三季度报告正文 第二节 公司基本情况 一、主要会计数据和财务指标 利尔化学股份有限公司 2018 年第三季度报告正文 1 利尔化学股份有限公司 2018 年第三季度报告正文 公司是否需追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期末 | 上年度末 | | 本报告期末比上年度末增减 | | --- | --- | --- | --- | --- | | 总资产(元) | 5,828,229,162.31 | 4,515,109,051.64 | | 29.08% | | 归属于上市公司股东 ...
利尔化学(002258) - 2018 Q2 - 季度财报
2018-08-03 16:00
利尔化学股份有限公司 2018 年半年度报告全文 利尔化学股份有限公司 2018 年半年度报告 2018 年 08 月 1 利尔化学股份有限公司 2018 年半年度报告全文 第一节 重要提示、目录和释义 公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容的 真实、准确、完整,不存在虚假记载、误导性陈述或重大遗漏,并承担个别和 连带的法律责任。 公司负责人尹英遂、主管会计工作负责人古美华及会计机构负责人(会计主 管人员)符眉冷声明:保证本半年度报告中财务报告的真实、准确、完整。 所有董事均已出席了审议本报告的董事会会议。 本报告中涉及的未来发展计划等前瞻性陈述,不构成公司对投资者的实质 承诺,请投资者注意投资风险。 公司存在市场竞争风险、原材料价格波动风险、环保风险、安全生产风险、 大规模建设投入导致利润下滑的风险、公司快速发展的管理风险,敬请广大投 资者注意投资风险。详细内容见本报告"第四节 十、公司面临的风险和应对措 施"。 公司计划不派发现金红利,不送红股,不以公积金转增股本。 2 | | | | 2018 | 年半年度报告 1 | | --- | --- | | 第一节 | 重要提示、释义 ...